Shandong Anxin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (8:1) (PROCESS IV), with a corresponding US DMF Number 33540.
Remarkably, this DMF maintains an Active status since its submission on February 21, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 14, 2019, and payment made on February 20, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II